Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Quadrant Management

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 5
Average round size
info
The average size of a deal this fund participated in
$12M
Portfolio companies 3
Rounds per year 0.11
Lead investments 1
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.40
Key employees 5

Areas of investment

  • Health Care
  • Medical Device
  • Health Diagnostics
  • Virtual Reality
  • Biotechnology

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Activation, Inc. New York, New York, United States
Beijing Hualian Group Beijing, Beijing, China
Big Red Ventures Ithaca, New York, United States
Bootstrap Incubation California, Solana Beach, United States
BroadVision California, Redwood City, United States
Citibank India India, Maharashtra, Mumbai
Cool Japan Fund Chiyoda, Japan
Define Ventures California, San Francisco, United States
Emirates NBD Dubai, United Arab Emirates
Far East Horizon China, Hong Kong, Hong Kong Island
Geon Investment Kyonggi-do, Seongnam, South Korea
MakerBot Brooklyn, New York, United States
One East Partners -
SIIF Chiba, Japan, Minato
Terra Funda -
Tomahawk Group -
Weiyin Fund Management Beijing, Beijing, China
Zaffre Investments Boston, Massachusetts, United States
Zheke Investment China, Hangzhou, Zhejiang
Zhi Xin Qiye Guanli China, Shaanxi, Xian Shi

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Vantem Global

Civil Engineering
Construction
07 Jul 2022 Greensboro, North Carolina, United States

Vantem Global

Civil Engineering
Construction
$10M14 Jun 2022 Greensboro, North Carolina, United States

Wandercraft

Health Care
Medical Device
Robotics
$47M20 Jan 2022 Paris, Ile-de-France, France

SyncThink

Biotechnology
Health Care
Health Diagnostics
Medical Device
Virtual Reality
$3M10 Jan 2018 Palo Alto, California, United States

SyncThink

Biotechnology
Health Care
Health Diagnostics
Medical Device
Virtual Reality
01 Jan 2011 Palo Alto, California, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Quadrant Management?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 5
Average round size 12M
Rounds per year 0.11
Peak activity year 2022
Lead investments 1
Follow on index 0.40
Group Appearance index 0.80

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Vantem Global

Civil Engineering
Construction
07 Jul 2022 Greensboro, North Carolina, United States

Vantem Global

Civil Engineering
Construction
$10M14 Jun 2022 Greensboro, North Carolina, United States

Wandercraft

Health Care
Medical Device
Robotics
$47M20 Jan 2022 Paris, Ile-de-France, France

SyncThink

Biotechnology
Health Care
Health Diagnostics
Medical Device
Virtual Reality
$3M10 Jan 2018 Palo Alto, California, United States

SyncThink

Biotechnology
Health Care
Health Diagnostics
Medical Device
Virtual Reality
01 Jan 2011 Palo Alto, California, United States
Crunchbase icon

Content report

The following text will be sent to our editors: